UPDATE 3-Coronavirus vaccine maker CureVac plans U.S. listing in July

German drugmaker CureVac, in which the government is taking a sizeable stake to help fund a COVID-19 vaccine, is planning an initial public offering in the United States next month, a finance ministry document seen by Reuters on Monday showed.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.